BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 1243836)

  • 1. [Effect of somatostatin and bromocriptin (CB-154) on growth hormone secretion in acromegaly].
    Althoff PH; Neubauer M; Handzel R; Schöffling K
    Verh Dtsch Ges Inn Med; 1975; 81():1515-20. PubMed ID: 1243836
    [No Abstract]   [Full Text] [Related]  

  • 2. [Acromegaly. Recent physiopathological and therapeutic acquisitions].
    Silvestrini F
    Minerva Med; 1979 Mar; 70(15):1065-8. PubMed ID: 108635
    [No Abstract]   [Full Text] [Related]  

  • 3. [100 years of acromegaly: general lessons about a rare disease].
    Lamberts SW
    Ned Tijdschr Geneeskd; 1986 May; 130(20):902-4. PubMed ID: 2873513
    [No Abstract]   [Full Text] [Related]  

  • 4. [Medical treatment of acromegaly. Somatostatin analogs offer a real hope].
    Kuhn JM; Héron I
    Rev Prat; 1992 Nov; 42(18):2303-7. PubMed ID: 1363585
    [No Abstract]   [Full Text] [Related]  

  • 5. Dopaminergic control of growth hormone secretion in normal and acromegalic subjects.
    Molinatti GM; Camanni F; Massara F; Isaia GC
    Panminerva Med; 1975 Apr; 17(4):101-6. PubMed ID: 1153217
    [No Abstract]   [Full Text] [Related]  

  • 6. [Determination of growth hormone response to thyreoliberin in the evaluation of lisuride therapy of acromegaly].
    Felt V; Nedvídková J
    Vnitr Lek; 1982 Aug; 28(8):756-61. PubMed ID: 6814061
    [No Abstract]   [Full Text] [Related]  

  • 7. Growth hormone and changes in the secretion of thyrotropic hormone after thyrotropin-releasing hormone (TRH): ineffectiveness of dopaminergic stimulation.
    Felt V; Nedvídková J
    Endokrinologie; 1982 Oct; 80(2):201-6. PubMed ID: 6819130
    [No Abstract]   [Full Text] [Related]  

  • 8. [Bromocriptin treatment of acromegaly (author's transl)(proceedings)].
    Bricaire H; Strauch G; Boutonnat Y
    Ann Endocrinol (Paris); 1976; 37(4):301-2. PubMed ID: 1037361
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term treatment of acromegaly with lisuride: differences of effect on growth hormone and somatomedin.
    Marek J; Srámková J; Schüllerová M; Stĕpán J; Schreiberová O
    Endokrinologie; 1981 Dec; 78(2-3):175-85. PubMed ID: 7037372
    [No Abstract]   [Full Text] [Related]  

  • 10. [Fall of the growth hormone levels in acromegalics after bromocryptin (author's transl)].
    Dolecek R
    Cas Lek Cesk; 1976 Aug; 115(33-34):1056-7. PubMed ID: 989744
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies with lergotrile mesylate in acromegaly.
    Kleinberg DL; Schaaf M; Frantz AG
    Fed Proc; 1978 Jun; 37(8):2198-201. PubMed ID: 658458
    [No Abstract]   [Full Text] [Related]  

  • 12. [Long-term treatment of acromegaly with a somatostatin analog].
    Vest S
    Ugeskr Laeger; 1987 Aug; 149(34):2263. PubMed ID: 2897734
    [No Abstract]   [Full Text] [Related]  

  • 13. Successful treatment of acromegaly with bromocriptine.
    Thorner MO; Besser GM
    Postgrad Med J; 1976; 52suppl 1():71-4. PubMed ID: 959128
    [No Abstract]   [Full Text] [Related]  

  • 14. The somatostatin analogue SMS 201-995 in acromegaly: prolonged, preferential suppression of growth hormone but not pancreatic hormones.
    George SR; Hegele RA; Burrow GN
    Clin Invest Med; 1987 Jul; 10(4):309-15. PubMed ID: 2888554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term treatment of acromegaly with Sandostatin (SMS 201-995). Normalization of most anomalous growth hormone responses.
    Pieters GF; van Liessum PA; Smals AG; van Gennep JA; Benraad TJ; Kloppenborg PW
    Acta Endocrinol Suppl (Copenh); 1987; 286():9-18. PubMed ID: 2892339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of dironyl in the treatment of acromegaly and hyperprolactinemia].
    Felt V; Nedvídková J
    Vnitr Lek; 1985 Oct; 31(10):980-5. PubMed ID: 4090298
    [No Abstract]   [Full Text] [Related]  

  • 17. Somatostatin analogs in the treatment of acromegaly.
    Lamberts SW; Reubi JC; Krenning EP
    Endocrinol Metab Clin North Am; 1992 Sep; 21(3):737-52. PubMed ID: 1355729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical treatment of acromegaly.
    Goldfine ID
    Annu Rev Med; 1978; 29():407-15. PubMed ID: 25606
    [No Abstract]   [Full Text] [Related]  

  • 19. Octreotide represses secretory-burst mass and nonpulsatile secretion but does not restore event frequency or orderly GH secretion in acromegaly.
    Biermasz NR; Pereira AM; Frölich M; Romijn JA; Veldhuis JD; Roelfsema F
    Am J Physiol Endocrinol Metab; 2004 Jan; 286(1):E25-30. PubMed ID: 14506078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term bromocriptine treatment and somatostatin in acromegaly.
    Gáspár L; László FA
    Endokrinologie; 1980 Oct; 76(2):152-62. PubMed ID: 6108852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.